Skip to content
MMJ Gazette
  Tuesday 26 August 2025
  • About
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Authors
  • Home
  • News
  • CBD
  • Cannabis
  • Drugs
  • Marijuana
  • Tobacco
  • Law
Trending
August 23, 2025South Dakota Marijuana Industry Rallies Behind Crackdown on Hemp THC August 22, 2025Florida Court Says Medical Marijuana Patients Can Own Guns August 7, 2025Los Angeles Greenlighted Massive Fee Hikes for Cannabis Operators—And Businesses Say It Could Break Them August 6, 2025Ayr Wellness to Shutter Grow Sites in Massachusetts and Nevada Amid Financial Strain August 4, 2025Cannabis Businesses Face Tightrope Act as Rules Shift State to State August 3, 2025Cannabis Dispensaries Rethink Retail: Design That Sells, Not Just Serves August 2, 2025Legal Weed’s Tax Nightmare: How Cannabis Firms Are Pushing Back Against 280E August 2, 2025Kentucky Gears Up for First Legal Medical Marijuana Sales by Autumn July 31, 2025Hemp THC Ban Pulled from Senate Bill After McConnell–Paul Face-Off July 30, 2025Oklahoma’s Marijuana Legalisation Fight Is Back—And It’s Getting Personal
MMJ Gazette
MMJ Gazette
  • About
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Authors
MMJ Gazette
  Drugs  Court Documents Suggest DEA Rigged Marijuana Rescheduling Process
DrugsMarijuanaNews

Court Documents Suggest DEA Rigged Marijuana Rescheduling Process

Lars BeckersLars Beckers—March 10, 20250
FacebookTwitterPinterestLinkedInTumblrRedditVKWhatsAppEmail

Newly surfaced court documents have reignited suspicions that the U.S. Drug Enforcement Administration (DEA) intentionally stacked the deck against marijuana rescheduling. A lawsuit filed by a group of pro-cannabis doctors claims the agency handpicked participants to tilt the outcome in its favor—excluding key voices that supported the change.

The lawsuit, filed by Doctors for Drug Policy Reform (DDPR) in the U.S. Court of Appeals for the D.C. Circuit, points to internal DEA records showing a questionable selection process. Of 163 applicants, only 25 were chosen under undisclosed criteria, while officials from cannabis-friendly states like New York and Colorado were outright rejected. Even more concerning, the documents suggest the DEA actively assisted nearly a dozen opponents of marijuana rescheduling.

With the cannabis industry watching closely, these revelations fuel skepticism over whether the rescheduling process is truly impartial—or if it’s just another bureaucratic blockade to maintain the status quo.

Evidence of Bias Sparks Legal Battle

DDPR’s lawsuit, originally filed in November, seeks transparency. The group wants the DEA to either redo the witness selection process or, at the very least, explain how it made its choices.

For Dr. Bryon Adinoff, an addiction psychiatrist and president of DDPR, the court documents confirm long-standing fears. “It confirms what we thought,” he told MJBizDaily, pointing to the DEA’s selective approval of testimonies.

• The agency allowed testimony from just 25 individuals out of 163 who applied.
• Rejections included officials from pro-cannabis states like New York and Colorado.
• The DEA allegedly assisted nearly a dozen opponents of rescheduling.

If the DEA’s process was indeed rigged, Adinoff argues that stopping or restarting it would be better than allowing a biased decision to stand. “We’re better off arguing the case where we are now than going forward and having it not work in our favor,” he said.

Why Rescheduling Matters for the Cannabis Industry

The push to move marijuana from Schedule 1 to Schedule 3 under federal law is more than just symbolic. The $32 billion U.S. cannabis industry stands to gain major financial benefits, particularly when it comes to taxes.

Under current law, cannabis businesses are barred from deducting standard expenses due to IRS tax code 280E, which applies to Schedule 1 and Schedule 2 substances. Rescheduling would lift that restriction, allowing businesses to operate under fairer tax rules.

It could also open the door for broader cannabis reform at the federal level. Some believe that a DEA endorsement of rescheduling could pressure Congress to take further action on stalled marijuana policy changes.

Ongoing Appeal Seeks to Remove DEA from the Process

The DEA has long been accused of obstructing cannabis policy reform. The latest legal battle isn’t just about this specific rescheduling attempt—it’s about whether the DEA should have the final say at all.

A separate appeal argues that the DEA should be removed as the primary decision-maker on marijuana scheduling, given its history of resistance. That case remains unresolved, but it signals growing frustration with how the agency handles cannabis-related decisions.

For now, the DEA maintains that it followed legal protocol. But with more documents coming to light, the pressure is mounting for the agency to defend its process—or risk losing credibility altogether.

FacebookTwitterPinterestLinkedInTumblrRedditVKWhatsAppEmail

Lars Beckers

Lars Beckers is a distinguished senior content writer at MMJ Gazette, bringing a wealth of experience and expertise to the realm of medical marijuana and cannabis-related content. With a deep understanding of the industry and a passion for sharing knowledge, Lars's articles offer readers comprehensive insights and engaging narratives in the dynamic world of cannabis. Known for his meticulous research, clarity of expression, and commitment to delivering high-quality content, Lars brings a seasoned perspective to his work, educating and informing audiences on the latest trends and developments in the field.

Pre-Rolls Poised to Overtake Flower as Top Cannabis Product in Canada
High Tide Expands in Ontario with Two New Canna Cabana Stores
Related posts
  • Related posts
  • More from author
Marijuana

South Dakota Marijuana Industry Rallies Behind Crackdown on Hemp THC

August 23, 20250
Marijuana

Florida Court Says Medical Marijuana Patients Can Own Guns

August 22, 20250
Cannabis

Los Angeles Greenlighted Massive Fee Hikes for Cannabis Operators—And Businesses Say It Could Break Them

August 7, 20250
Load more
Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

SEARCH
PROMOTIONS
RECENT POSTS
  • South Dakota Marijuana Industry Rallies Behind Crackdown on Hemp THC
  • Florida Court Says Medical Marijuana Patients Can Own Guns
  • Los Angeles Greenlighted Massive Fee Hikes for Cannabis Operators—And Businesses Say It Could Break Them
  • Ayr Wellness to Shutter Grow Sites in Massachusetts and Nevada Amid Financial Strain
  • Cannabis Businesses Face Tightrope Act as Rules Shift State to State
  • Cannabis Dispensaries Rethink Retail: Design That Sells, Not Just Serves
  • Legal Weed’s Tax Nightmare: How Cannabis Firms Are Pushing Back Against 280E
  • Kentucky Gears Up for First Legal Medical Marijuana Sales by Autumn
  • Hemp THC Ban Pulled from Senate Bill After McConnell–Paul Face-Off
  • Oklahoma’s Marijuana Legalisation Fight Is Back—And It’s Getting Personal
    © MMJ Gazette. 2024
    • About
    • Contact Us
    • Privacy Policy
    • Terms and Conditions
    • Authors